Richard Ramsden

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

D. Gareth Evans, Susan Huson, Dian Donnai et al. · Journal of Medical Genetics · 1992 · 466 citations · Full text

Neuro-oncology, Mendelian Disorder, Genetic Disorder +14

Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-year Period: Higher Incidence than Previously Thought

D. Gareth Evans, Anthony Moran, Andrew T. King et al. · Otology & Neurotology · 2005 · 414 citations

Preservation of residual hearing with cochlear implantation: How and why

Chris James, K Albegger, Rolf D. Battmer et al. · Acta Oto-Laryngologica · 2004 · 275 citations

Residual Hearing Conservation and Electroacoustic Stimulation with the Nucleus 24 Contour Advance Cochlear Implant

Bernard Fraysse, Ángel Ramos Macías, Olivier Sterkers et al. · Otology & Neurotology · 2006 · 234 citations

Predictors of the Risk of Mortality in Neurofibromatosis 2

Michael E. Baser, Jan M. Friedman, Dana Aeschliman et al. · The American Journal of Human Genetics · 2002 · 225 citations · Full text

Neuro-oncology, Fibrosis, Disease Progression +6